Dimeric Approaches to Anti-Cancer Chemotherapeutics

被引:52
作者
Hadden, M. K. [1 ]
Blagg, B. S. J. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
关键词
Anti-cancer; dimer; natural product dimers; synthetic dimers; bisintercalators;
D O I
10.2174/187152008785914743
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Numerous proteins responsible for cell proliferation and differentiation exist either as hetero or homodimers or become activated through dimerization as a key step in their respective signaling cascade. Many of these proteins have been identified as major components in oncogenic signaling pathways and have become popular targets for the development of anti-tumor agents. For this reason, bivalent anti-cancer drugs that could potentially interact with each monomer of a dimeric protein target have been developed. This review provides a brief background on prevalent dimeric drug targets within the anti-cancer field and focuses mainly on dimeric natural product and synthetic cancer chemotherapeutics.
引用
收藏
页码:807 / 816
页数:10
相关论文
共 88 条
[1]   Thalibealine, a novel tetrahydroprotoberberine-aporphine dimeric alkaloid from Thalictrum wangii [J].
Al-Howiriny, TA ;
Zemaitis, MA ;
Gao, CY ;
Hadden, CE ;
Martin, GE ;
Lin, FT ;
Schiff, PL .
JOURNAL OF NATURAL PRODUCTS, 2001, 64 (06) :819-822
[2]   Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90 - Evidence that coumarin antibiotics disrupt Hsp90 dimerization [J].
Allan, RK ;
Mok, D ;
Ward, BK ;
Ratajczak, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) :7161-7171
[3]   SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations [J].
Alley, MC ;
Hollingshead, MG ;
Pacula-Cox, CM ;
Wand, WR ;
Hartley, JA ;
Howard, PW ;
Gregson, SJ ;
Thurston, DE ;
Sausville, EA .
CANCER RESEARCH, 2004, 64 (18) :6700-6706
[4]   Synthesis and analysis of polyethylene glycol linked P-glycoprotein-specific homodimers based on (-)-stipiamide [J].
Andrus, MB ;
Turner, TM ;
Updegraff, EP ;
Sauna, ZE ;
Ambudkar, SV .
TETRAHEDRON LETTERS, 2001, 42 (23) :3819-3822
[5]  
[Anonymous], 1979, CHINESE MED J-PEKING, V92, P811
[6]   Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents [J].
Antonini, I ;
Polucci, P ;
Magnano, A ;
Sparapani, S ;
Martelli, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (21) :5244-5250
[7]   Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents [J].
Antonini, I ;
Polucci, P ;
Magnano, A ;
Gatto, B ;
Palumbo, M ;
Menta, E ;
Pescalli, N ;
Martelli, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (14) :3109-3115
[8]   Synthesis and biological evaluation of new asymmetrical bisintercalators as potential antitumor drugs [J].
Antonini, Ippolito ;
Santoni, Giorgio ;
Lucciarini, Roberta ;
Amantini, Consuelo ;
Sparapani, Silvia ;
Magnano, Amelia .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) :7198-7207
[9]   NOVEL INTERSTRAND CROSS-LINKS INDUCED BY THE ANTITUMOR ANTIBIOTIC CARZINOPHILIN AZINOMYCIN-B [J].
ARMSTRONG, RW ;
SALVATI, ME ;
NGUYEN, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (08) :3144-3145
[10]   Chromophore-modified bisnaphthalimides:: DNA recognition, topoisomerase inhibition, and cytotoxic properties of two mono- and bisfuronaphthalimides [J].
Bailly, C ;
Carrasco, C ;
Joubert, A ;
Bal, C ;
Wattez, N ;
Hildebrand, MP ;
Lansiaux, A ;
Colson, P ;
Houssier, C ;
Cacho, M ;
Ramos, A ;
Braña, MF .
BIOCHEMISTRY, 2003, 42 (14) :4136-4150